Jessica Lucero
Adult Health · Las Vegas, NVNPI 1487726519
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,249 of the $6,060 with a category attached, or 86.6%. It is spread thinly across 27 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,793 and has fallen 51.3% since, to $873 in 2025.
Across 318 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$890
- Boehringer Ingelheim$607
- Novo Nordisk$386
- Abbott$329
- plus $1K from 21 others
What the payments were for
- Consulting fees$80013%
- Food & beverage$5,24987%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 75 | $1,385 |
| AbbVie | 70 | $1,049 |
| Biohaven Pharmaceuticals, Inc. | 9 | $890 |
| Boehringer Ingelheim | 43 | $607 |
| Novo Nordisk | 19 | $386 |
| Abbott | 20 | $329 |
| Astellas Pharma US Inc | 12 | $235 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $191 |
| Ferring Pharmaceuticals Inc. | 7 | $188 |
| Pfizer | 8 | $120 |
| Novartis | 5 | $77 |
| Exact Sciences | 4 | $70 |
| Daiichi Sankyo Inc. | 4 | $69 |
| Phathom Pharmaceuticals, Inc. | 4 | $65 |
| Bayer | 3 | $48 |
| Amgen | 3 | $47 |
| Merck | 3 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $45 |
| Organogenesis Inc. | 3 | $44 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Lilly USA, LLC | 2 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $14 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
- FARXIGA$140
- BREZTRI$140
How this compares
$6,060 in reported general payments places this provider in the 85th percentile of 90 adult health providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 59 | $68,390 |
| OzempicSemaglutide | 53 | $62,425 |
| JardianceEmpagliflozin | 45 | $35,639 |
| EliquisApixaban | 41 | $34,547 |
| JanuviaSitagliptin Phosphate | 19 | $29,629 |
| XareltoRivaroxaban | 42 | $16,901 |
| Repatha SureclickEvolocumab | 22 | $13,161 |
| Wellbutrin SrBupropion Hcl | 12 | $10,355 |
| TrulicityDulaglutide | 22 | $5,759 |
| EdarbiAzilsartan Medoxomil | 11 | $2,570 |
| Atorvastatin Calcium | 227 | $1,826 |
| LantusInsulin Glargine,hum.Rec.Anlog | 25 | $1,713 |
| Levothyroxine Sodium | 189 | $1,501 |
| Bupropion XlBupropion Hcl | 57 | $1,495 |
| PaxlovidNirmatrelvir/Ritonavir | 11 | $1,429 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $25 | $74,14981 claims |
| Novo NordiskOzempic | $386 | $62,42553 claims |
| PfizerEliquis, Paxlovid | $120 | $35,97752 claims |
| Boehringer IngelheimJardiance | $607 | $35,63945 claims |
| MerckJanuvia | $46 | $29,62919 claims |
| AbbVieSynthroid | $1,049 | $1,12122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 90 adult health providers in Nevada.
Other adult health in Las Vegas
- Marcia Castro-RosenbergLas Vegas$64K
- Amanda SquiersLas Vegas$36K
- Jasmina FornbacherLas Vegas$14K
- Marcella PomeranzLas Vegas$14K
- Karisa SonLas Vegas$10K
- Monica LynamLas Vegas$5K
- Thomas McNeilLas Vegas$5K
- Roger ConantLas Vegas$4K
- Ruth RamirezLas Vegas$4K
- Gener CruzLas Vegas$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.